In Silico Design of E3 Ubiquitin-Protein Ligase NEDD4-1 Inhibitors: An Alternative Approach for Targeting the MAPK Pathway in Cancer Therapy
Keyword(s):
Among all the several targets in common use in the antitumor therapies, the pharmacologicinhibition of the MAPK (Mitogen Activated Protein Kinase) pathway represents an efficienttherapeutic approach [1]. [...]
1994 ◽
Vol 269
(5)
◽
pp. 3534-3538
2009 ◽
Vol 2
(6)
◽
pp. 566-571
◽
1996 ◽
Vol 271
(45)
◽
pp. 28097-28104
◽
2013 ◽
Vol 19
(9)
◽
pp. 2301-2309
◽